82 related articles for article (PubMed ID: 1289605)
1. [Effect of oral adsorbent (AST-120) in the rat model of chronic renal failure induced by adriamycin].
Yoshida Y; Ise M
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1055-9. PubMed ID: 1289605
[TBL] [Abstract][Full Text] [Related]
2. [The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
Yoshida Y; Sakai T; Asakura K; Sugano M; Ise M; Uehara Y
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1001-8. PubMed ID: 2263021
[TBL] [Abstract][Full Text] [Related]
3. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
Imai E; Takenaka M; Isaka Y; Moriyama T; Akagi Y; Kakuchi J; Fujii T; Ito T; Hori M; Horio M; Syoji T; Tsubakihara Y
Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
[TBL] [Abstract][Full Text] [Related]
4. Effect of an oral adsorbent (AST-120) in rats with daunomycin-induced chronic renal failure.
Shimizu K; Maeda K; Shibata M; Ise M; Sugano M; Uehara Y
Nihon Jinzo Gakkai Shi; 1991 May; 33(5):507-11. PubMed ID: 1895550
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral adsorbent in the rat model of chronic renal failure.
Yoshida Y; Sakai T; Ise M
Nephron; 1992; 62(3):305-14. PubMed ID: 1436344
[TBL] [Abstract][Full Text] [Related]
6. [Pathological study on the effect of oral adsorbent AST-120 on chronic renal failure in rats].
Kuwao S; Sakai T; Kumano K; Ise M; Uehara Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):731-41. PubMed ID: 1770633
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
[TBL] [Abstract][Full Text] [Related]
8. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamagishi S
Metabolism; 2011 Feb; 60(2):260-4. PubMed ID: 20189611
[TBL] [Abstract][Full Text] [Related]
9. [Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats].
Sakai T; Kumano K; Takara S; Kuwao S; Ise M; Sugano M; Uehara Y
Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):359-65. PubMed ID: 2747009
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study.
Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T
Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455
[TBL] [Abstract][Full Text] [Related]
12. [Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein].
Niimura F; Ise M; Uehara Y; Kumano K; Sakai T
Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):261-71. PubMed ID: 1630028
[TBL] [Abstract][Full Text] [Related]
13. New approach for chronic renal failure model by direct kidney injection of doxorubicin in rats.
Yoneko M; Kamei J; Ito CF; Kojima J
Methods Find Exp Clin Pharmacol; 2007; 29(6):389-94. PubMed ID: 17922066
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
Aoyama I; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
[TBL] [Abstract][Full Text] [Related]
15. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
Tumur Z; Niwa T
J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
[TBL] [Abstract][Full Text] [Related]
16. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
[TBL] [Abstract][Full Text] [Related]
17. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
[TBL] [Abstract][Full Text] [Related]
18. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
[TBL] [Abstract][Full Text] [Related]
19. Early morphological changes of tubules in rats with chronic renal failure.
Okada K; Takahashi S; Nagura Y; Hatano M; Shimamura T
Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):65-70. PubMed ID: 1593798
[TBL] [Abstract][Full Text] [Related]
20. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure.
Motojima M; Nishijima F; Ikoma M; Kawamura T; Yoshioka T; Fogo AB; Sakai T; Ichikawa I
Kidney Int; 1991 Sep; 40(3):461-9. PubMed ID: 1787646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
